Indomira Revenue and Competitors
Estimated Revenue & Valuation
- Indomira's estimated annual revenue is currently $775k per year.
- Indomira's estimated revenue per employee is $155,000
Employee Data
- Indomira has 5 Employees.
- Indomira grew their employee count by 0% last year.
Indomira's People
Name | Title | Email/Phone |
---|---|---|
1 | President | Reveal Email/Phone |
Indomira Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $1.7M | 11 | -54% | N/A | N/A |
#2 | $18.8M | 121 | 11% | N/A | N/A |
#3 | $6.8M | 44 | 7% | N/A | N/A |
#4 | $0.8M | 5 | 0% | N/A | N/A |
#5 | $35.8M | 185 | 38% | N/A | N/A |
#6 | $1.7M | 11 | 10% | N/A | N/A |
#7 | $2.6M | 17 | 0% | N/A | N/A |
#8 | $0.8M | 5 | 0% | N/A | N/A |
#9 | $8.1M | 52 | 4% | N/A | N/A |
#10 | $0.8M | 5 | 0% | N/A | N/A |
What Is Indomira?
Indomira is a U.S. and New Zealand-based phytopharmaceutical company dedicated to unlocking the healing potential of medical Cannabis. We are developing clinically-proven medicines that enhance everyday health, provide preventive strategies, and address modern conditions. As prohibition gives way to changing sentiment, an unprecedented wave of research is validating the efficacy of Cannabis as a medical treatment and a wellness therapy. This is providing hope and solutions for managing conditions such as cancer, chronic pain, epilepsy, and multiple sclerosis. However, more work is needed to build the scientific framework for safe and effective use, educate healthcare professionals, and change public awareness. This is at the heart of our mission. Through research, education, and knowledge-sharing, we’re inspiring new thinking and informed decisions about Cannabis and health.
keywords:N/AN/A
Total Funding
5
Number of Employees
$775k
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.4M | 5 | 0% | N/A |
#2 | $0.7M | 5 | N/A | N/A |
#3 | $0.4M | 5 | 25% | N/A |
#4 | $0.4M | 5 | 0% | N/A |
#5 | $0.7M | 6 | -57% | N/A |